Potentiation of endogenous nitric oxide with superoxide dismutase inhibits platelet-mediated thrombosis in injured and stenotic arteries.
OBJECTIVE
We tested the hypothesis that dismutation of superoxide anion increases endogenous levels of nitric oxide, resulting in inhibition of cyclic variations in blood flow in arteries that are injured and stenotic.


BACKGROUND
Platelet adhesion and aggregation leading to cyclic flow variations might result, in part, from generation of superoxide anion that can deplete endogenously produced nitric oxide.


METHODS
Spontaneous cyclic flow variations, monitored with a proximal Doppler probe, were induced in the carotid artery of anesthetized rabbits by clamping the vessel with forceps and placing a high grade stenosis at the site of injury. Bovine copper/zinc superoxide dismutase (12 mg/kg body weight, n = 5), a synthetic low molecular weight mimetic (12 mg/kg, n = 8) or buffer vehicle (n = 8) was administered intravenously as divided boluses over 45 min, and the frequency of cyclic flow variations was monitored for 4 h.


RESULTS
Cyclic flow variations remained stable for 4 h in vehicle-treated animals (15 +/- 1 [mean +/- SEM]/30 min at baseline and 16 +/- 1/30 min after 4 h, n = 8) but exhibited a marked and persistent reduction in animals given copper/zinc superoxide dismutase (from 14 +/- 1/30 min at baseline to 4 +/- 1/30 min after 4 h) or the mimetic (from 15 +/- 1/30 min at baseline to 3 +/- 1/30 min after 4 h, p < 0.005). They were restored in three of four mimetic-treated animals during infusion of NG-monomethyl- L-arginine (100 mg/kg), an inhibitor of nitric oxide production. In addition, levels of cyclic guanosine 5'-monophosphate in platelets were elevated after administration of the mimetic (from 2.4 +/- 0.5 fmol/10(6) platelets at baseline to 4.9 +/- 0.6 fmol/10(6) platelets 45 min after the mimetic, p < 0.03, n = 6), whereas mean arterial blood pressure was decreased and flow velocity in the carotid artery was increased consistent with mediation of the effect on cyclic flow variations by increased endogenous nitric oxide.


CONCLUSIONS
Dismutation of superoxide anion appears to attenuate platelet thrombus formation at a site of vessel injury by potentiation of endogenously produced nitric oxide. This approach may have utility to inhibit platelet-rich thrombosis in injured and stenotic arteries where production of superoxide anion is increased.
Meng
Y Y
YY
Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri 63110.
Trachtenburg
J
J
Ryan
U S
US
Abendschein
D R
DR
D000818:Animals; D001158:Arteries / Q000293:injuries* / Q000473:pathology*; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003251:Constriction, Pathologic / Q000097:blood / Q000150:complications / Q000209:etiology; D006152:Cyclic GMP / Q000097:blood; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D009569:Nitric Oxide / Q000502:physiology*; D005996:Nitroglycerin / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use; D011817:Rabbits; D011897:Random Allocation; D013482:Superoxide Dismutase / Q000627:therapeutic use*; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors
D002317:Cardiovascular Agents; D009942:Organometallic Compounds; C089774:SC 52608; D009569:Nitric Oxide; D013482:Superoxide Dismutase; D005996:Nitroglycerin; D006152:Cyclic GMP; D001241:Aspirin